|
IMAGING
MDCT
urography of upper tract urothelial neoplasms
Caoili EM, Cohan RH, Inampudi P, Ellis JH, Shah RB, Faerber GJ, Montie
JE
Department of Radiology, University of Michigan Health System, Ann Arbor,
MI, USA
AJR Am J Roentgenol. 2005; 184: 1873-81
-
Objective: The
purpose of our study was to review the MDCT urography appearance of
pathologically proven transitional cell carcinomas of the renal collecting
system and ureter and to correlate the MDCT urography findings with
pathology findings.
- Materials
and Methods: Of 370 MDCT urography examinations performed over
an 18-month period, 18 patients were diagnosed with 27 renal collecting
system or ureteral urothelial neoplasms at endoscopic biopsy (n = 8)
or surgery (n = 19). Initial MDCT reports were reviewed to determine
the sensitivity of original reviewers in detecting these neoplasms.
Two radiologists also retrospectively reviewed these scans and characterized
the CT appearance of the neoplasms on both axial CT and 3D reformatted
images. Findings at retrospective review were correlated with pathology
results to determine whether any CT features could be used to predict
tumor grade.
-
Results:
Eighteen of 27 neoplasms were prospectively identified on MDCT urography,
and an additional six neoplasms were detected on retrospective review.
Three ureteral neoplasms could not be visualized. The 24 retrospectively
detected neoplasms had three distinct MDCT appearances: circumferential
urothelial wall thickening (n = 14), small masses (> 5 mm in maximal
diameter) (n = 5), and large masses (> 5 mm in maximal diameter)
(n = 5). All detected lesions could be seen on axial excretory phase
images provided wide window settings were reviewed; however, only six
were detected on 3D reconstructions. MDCT urography appearance did not
correlate with tumor grade.
-
Conclusion:
MDCT urography is a promising technique for detecting upper urinary
tract neoplasms. The static 3D reconstructions used in this study are
insufficient for visualization. Axial image review remains essential
for tumor identification.
- Editorial
Comment
Multidetector CT (MDCT) urography has been shown to be a promising and
effective single comprehensive examination in the evaluation of patients
with hematuria or with risk for the development of urothelial malignancies.
During MDCT urography the images are obtained in the unenhanced phase
(detection of calculi), nephrographic-phase (detection of renal masses)
and excretory-phase (detection of urothelial lesions).
The authors nicely presents the imaging findings of 24 neoplasms retrospectively
detected in 18 out 370 patients submitted to the “state of the
art” MDCT urography. In this investigation 89% of malignant upper
tract foci were detectable with this relatively new technique. One of
the several important contributions showed by this study was the possibility
of detecting small tumors. These small tumors, similarly to larger ones,
were both papillary and flat and both high grade and low grade. The
authors were able to retrospectively detect small (< 5 mm) tumors.
Similarly to larger lesions, these tumors appeared as intraluminal masses
and ureteral wall thickening. Most of these small lesions were seen
only on the axial images and with wide window settings.
Our early experience with MDCT has also been rewarding since we have
been able to prospectively detect some cases of small urothelial malignancies,
two of these confirmed as carcinoma in situ. The use of virtual endoscopy
in both of theses cases was useful to confirm the presence of such small
lesions and to differentiate them from ectopic or prominent papillae.
Additional information was also offered to the surgeon when endoscopic
resection was the modality of treatment.
As pointed out by the authors MDCT will not identify all urothelial
tumors due to either its peculiar location or small size or more frequently
due to technical problems (lack of opacification of the pelviocalyceal
system and ureter).
Dr.
Adilson Prando
Chief, Department of Radiology
Vera Cruz Hospital
Campinas, São Paulo, Brazil |